Literature DB >> 9527716

[Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery].

R Larumbe1.   

Abstract

We attempt to determine the utility of CERAD in detecting early Alzheimer's disease (AD). CERAD battery was administered to a group of 14 control subjects, 12 patients with possible dementia prodromes and to patients with Alzheimer's disease stratified according to severity (16 mild, 8 moderate). Other measures as some subtest of the Wechsler memory scale and the Rey Complex Figure Test were also applied. Delayed recall as well as logical memory of Wechsler memory scale were found to be the best discriminators for detecting very mild cases of AD (Prodromes) (p < 0.05). None of the memory test proved of value in staging the disorder. Visuospatial functions are better determinants of the progression of the illness. Fluency also distinguish between control subjects and very mild cases. These findings suggest that delayed recall memory and probably executive function are the most useful and sensitive indicators of Alzheimer's disease.

Entities:  

Mesh:

Year:  1997        PMID: 9527716

Source DB:  PubMed          Journal:  Rev Med Univ Navarra        ISSN: 0556-6177


  2 in total

1.  Methods to improve the detection of mild cognitive impairment.

Authors:  William R Shankle; A Kimball Romney; Junko Hara; Dennis Fortier; Malcolm B Dick; James M Chen; Timothy Chan; Xijiang Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

2.  A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study.

Authors:  Kay L Cox; Elizabeth V Cyarto; Kathryn A Ellis; David Ames; Patricia Desmond; Pramit Phal; Matthew J Sharman; Cassandra Szoeke; Christopher C Rowe; Colin L Masters; Emily You; Sally Burrows; Michelle M Y Lai; Nicola T Lautenschlager
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.